Skip to main content

Advertisement

Log in

Infarct Volume After Hyperacute Infusion of Hypertonic Saline in a Rat Model of Acute Embolic Stroke

  • Translational Research
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Introduction

Hypertonic saline (HS) can treat cerebral edema arising from a number of pathologic conditions. However, physicians are reluctant to use it during the first 24 h after stroke because of experimental evidence that it increases infarct volume when administered early after reperfusion. Here, we determined the effect of HS on infarct size in an embolic clot model without planned reperfusion.

Methods

A clot was injected into the internal carotid artery of male Wistar rats to reduce perfusion in the middle cerebral artery territory to less than 40 % of baseline, as monitored by laser-Doppler flowmetry. After 25 min, rats were randomized to receive 10 mL/kg of 7.5 % HS (50:50 chloride:acetate) or normal saline (NS) followed by a 0.5 mL/h infusion of the same solution for 22 h.

Results

Infarct volume was similar between NS and HS groups (in mm3: cortex 102 ± 65 mm3 vs. 93 ± 49 mm3, p = 0.72; caudoputamenal complex 15 ± 9 mm3 vs. 21 ± 14, p = 0.22; total hemisphere 119 ± 76 mm3 vs. 114 ± 62, p = 0.88, respectively). Percent water content was unchanged in the infarcted hemisphere (NS 81.6 ± 1.5 %; HS 80.7 ± 1.3 %, p = 0.16), whereas the HS-treated contralateral hemisphere was significantly dehydrated (NS 79.4 ± 0.8 %; HS 77.5 ± 0.8 %, p < 0.01).

Conclusions

HS reduced contralateral hemispheric water content but did not affect ipsilateral brain water content when compared to NS. Infarct volume was unaffected by HS administration at all evaluated locations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ducey JP, Mozingo DW, Lamiell JM, Okerburg C, Gueller GE. A comparison of the cerebral and cardiovascular effects of complete resuscitation with isotonic and hypertonic saline, hetastarch, and whole blood following hemorrhage. J Trauma. 1989;29:1510–8.

    Article  PubMed  CAS  Google Scholar 

  2. Fisher B, Thomas D, Peterson B. Hypertonic saline lowers raised intracranial-pressure in children after head trauma. J Neurosurg Anesthesiol. 1992;4:4–10.

    Article  PubMed  CAS  Google Scholar 

  3. Francony G, Fauvage B, Falcon D, Canet C, Dilou H, Lavagne P, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med. 2008;36:795–800.

    Article  PubMed  CAS  Google Scholar 

  4. Gemma M, Cozzi S, Tommasino C, Mungo M, Calvi MR, Cipriani A, et al. 7.5 % hypertonic saline versus 20 % mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol. 1997;9:329–34.

    Article  PubMed  CAS  Google Scholar 

  5. Koenig MA, Bryan M, Lewin JL 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70:1023–9.

    Article  PubMed  CAS  Google Scholar 

  6. Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery. 1999;44:1055–63; discussion 1063–4.

    Google Scholar 

  7. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10 %) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33:136–40.

    Article  PubMed  CAS  Google Scholar 

  8. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29:1550–5.

    Article  PubMed  CAS  Google Scholar 

  9. Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer’s solution versus hypertonic saline. Crit Care Med. 1998;26:1265–70.

    Article  PubMed  CAS  Google Scholar 

  10. Suarez JI, Qureshi AI, Bhardwaj A, Williams MA, Schnitzer MS, Mirski M, et al. Treatment of refractory intracranial hypertension with 23.4 % saline. Crit Care Med. 1998;26:1118–22.

    Article  PubMed  CAS  Google Scholar 

  11. Suarez JI, Qureshi AI, Parekh PD, Razumovsky A, Tamargo RJ, Bhardwaj A, et al. Administration of hypertonic (3 %) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1999;11:178–84.

    Article  PubMed  CAS  Google Scholar 

  12. Toung TJ, Hurn PD, Traystman RJ, Bhardwaj A. Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit Care Med. 2002;30:644–9.

    Article  PubMed  Google Scholar 

  13. Toung TJ, Tyler B, Brem H, Traystman RJ, Hurn PD, Bhardwaj A. Hypertonic saline ameliorates cerebral edema associated with experimental brain tumor. J Neurosurg Anesthesiol. 2002;14:187–93.

    Article  PubMed  Google Scholar 

  14. Worthley LI, Cooper DJ, Jones N. Treatment of resistant intracranial hypertension with hypertonic saline. Report of two cases. J Neurosurg. 1988;68:478–81.

    Article  PubMed  CAS  Google Scholar 

  15. Kerwin AJ, Schinco MA, Tepas JJ 3rd, Renfro WH, Vitarbo EA, Muehlberger M. The use of 23.4 % hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. J Trauma. 2009;67:277–82.

    Article  PubMed  CAS  Google Scholar 

  16. Raghavan M, Marik PE. Therapy of intracranial hypertension in patients with fulminant hepatic failure. Neurocrit Care. 2006;4:179–89.

    Article  PubMed  CAS  Google Scholar 

  17. Bhardwaj A, Harukuni I, Murphy SJ, Alkayed NJ, Crain BJ, Koehler RC, et al. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke. 2000;31:1694–701.

    Article  PubMed  CAS  Google Scholar 

  18. Chen CH, Toung TJ, Sapirstein A, Bhardwaj A. Effect of duration of osmotherapy on blood–brain barrier disruption and regional cerebral edema after experimental stroke. J Cereb Blood Flow Metab. 2006;26:951–8.

    Article  PubMed  CAS  Google Scholar 

  19. Yang GY, Betz AL. Reperfusion-induced injury to the blood–brain barrier after middle cerebral artery occlusion in rats. Stroke. 1994;25:1658–64; discussion 1664–5.

    Google Scholar 

  20. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke. 1998;29:159–65; discussion 166.

    Google Scholar 

  21. Zhang RL, Chopp M, Zhang ZG, Jiang Q, Ewing JR. A rat model of focal embolic cerebral ischemia. Brain Res. 1997;766:83–92.

    Article  PubMed  CAS  Google Scholar 

  22. Takahashi H, Kirsch JR, Hashimoto K, London ED, Koehler RC, Traystman RJ. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats. Stroke. 1996;27:2120–3.

    Article  PubMed  CAS  Google Scholar 

  23. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993;24:117–21.

    Article  PubMed  CAS  Google Scholar 

  24. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10:290–3.

    Article  PubMed  CAS  Google Scholar 

  25. Toung TJ, Nyquist P, Mirski MA. Effect of hypertonic saline concentration on cerebral and visceral organ water in an uninjured rodent model. Crit Care Med. 2008;36:256–61.

    Article  PubMed  CAS  Google Scholar 

  26. Lee JY, Sagher O, Keep R, Hua Y, Xi G. Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. Neurosurgery. 2009;65:331–43; discussion 343.

    Google Scholar 

  27. Kahles T, Foerch C, Sitzer M, Schroeter M, Steinmetz H, Rami A, et al. Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent. Vascul Pharmacol. 2005;43:254–9.

    Article  PubMed  CAS  Google Scholar 

  28. Zeynalov E, Chen CH, Froehner SC, Adams ME, Ottersen OP, Amiry-Moghaddam M, et al. The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. Crit Care Med. 2008;36:2634–40.

    Article  PubMed  CAS  Google Scholar 

  29. Tseng MY, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ. Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage. Stroke. 2003;34:1389–96.

    Article  PubMed  CAS  Google Scholar 

  30. Muizelaar JP, Wei EP, Kontos HA, Becker DP. Cerebral blood flow is regulated by changes in blood pressure and in blood viscosity alike. Stroke. 1986;17:44–8.

    Article  PubMed  CAS  Google Scholar 

  31. Paczynski RP. Osmotherapy. Basic concepts and controversies. Crit Care Clin. 1997;13:105–29.

    Article  PubMed  CAS  Google Scholar 

  32. Heimann A, Takeshima T, Alessandri B, Noppens R, Kempski O. Effects of hypertonic/hyperoncotic treatment after rat cortical vein occlusion. Crit Care Med. 2003;31:2495–501.

    Article  PubMed  CAS  Google Scholar 

  33. Shackford SR, Zhuang J, Schmoker J. Intravenous fluid tonicity: effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg. 1992;76:91–8.

    Article  PubMed  CAS  Google Scholar 

  34. Hartl R, Medary MB, Ruge M, Arfors KE, Ghahremani F, Ghajar J. Hypertonic/hyperoncotic saline attenuates microcirculatory disturbances after traumatic brain injury. J Trauma. 1997;42:S41–7.

    Article  PubMed  CAS  Google Scholar 

  35. Forsyth LL, Liu-DeRyke X, Parker D Jr, Rhoney DH. Role of hypertonic saline for the management of intracranial hypertension after stroke and traumatic brain injury. Pharmacotherapy. 2008;28:469–84.

    Article  PubMed  CAS  Google Scholar 

  36. Ciesla DJ, Moore EE, Zallen G, Biffl WL, Silliman CC. Hypertonic saline attenuation of polymorphonuclear neutrophil cytotoxicity: timing is everything. J Trauma. 2000;48:388–95.

    Article  PubMed  CAS  Google Scholar 

  37. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol. 2002;168:1389–96.

    PubMed  CAS  Google Scholar 

  38. Loomis WH, Namiki S, Hoyt DB, Junger WG. Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators. Am J Physiol Cell Physiol. 2001;281:C840–8.

    PubMed  CAS  Google Scholar 

  39. Rhee P, Wang D, Ruff P, Austin B, DeBraux S, Wolcott K, et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med. 2000;28:74–8.

    Article  PubMed  CAS  Google Scholar 

  40. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol. 1998;161:6288–96.

    PubMed  CAS  Google Scholar 

  41. Coimbra R, Junger WG, Hoyt DB, Liu FC, Loomis WH, Evers MF. Hypertonic saline resuscitation restores hemorrhage-induced immunosuppression by decreasing prostaglandin E2 and interleukin-4 production. J Surg Res. 1996;64:203–9.

    Article  PubMed  CAS  Google Scholar 

  42. Coimbra R, Junger WG, Liu FC, Loomis WH, Hoyt DB. Hypertonic/hyperoncotic fluids reverse prostaglandin E2 (PGE2)-induced T-cell suppression. Shock. 1995;4:45–9.

    Article  PubMed  CAS  Google Scholar 

  43. Gushchin V, Stegalkina S, Alam HB, Kirkpatrick JR, Rhee PM, Koustova E. Cytokine expression profiling in human leukocytes after exposure to hypertonic and isotonic fluids. J Trauma. 2002;52:867–71.

    Article  PubMed  CAS  Google Scholar 

  44. Junger WG, Coimbra R, Liu FC, Herdon-Remelius C, Junger W, Junger H, et al. Hypertonic saline resuscitation: a tool to modulate immune function in trauma patients? Shock. 1997;8:235–41.

    Article  PubMed  CAS  Google Scholar 

  45. Attuwaybi B, Kozar RA, Gates KS, Moore-Olufemi S, Sato N, Weisbrodt NW, et al. Hypertonic saline prevents inflammation, injury, and impaired intestinal transit after gut ischemia/reperfusion by inducing heme oxygenase 1 enzyme. J Trauma. 2004;56:749–58; discussion 758–9.

    Google Scholar 

  46. Gurfinkel V, Poggetti RS, Fontes B, da Costa Ferreira Novo F, Birolini D. Hypertonic saline improves tissue oxygenation and reduces systemic and pulmonary inflammatory response caused by hemorrhagic shock. J Trauma. 2003;54:1137–45.

    Article  PubMed  CAS  Google Scholar 

  47. Powers KA, Zurawska J, Szaszi K, Khadaroo RG, Kapus A, Rotstein OD. Hypertonic resuscitation of hemorrhagic shock prevents alveolar macrophage activation by preventing systemic oxidative stress due to gut ischemia/reperfusion. Surgery. 2005;137:66–74.

    Article  PubMed  CAS  Google Scholar 

  48. Shields CJ, Winter DC, Manning BJ, Wang JH, Kirwan WO, Redmond HP. Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion. Arch Surg. 2003;138:9–14.

    Article  PubMed  CAS  Google Scholar 

  49. Angle N, Cabello-Passini R, Hoyt DB, Loomis WH, Shreve A, Namiki S, et al. Hypertonic saline infusion: can it regulate human neutrophil function? Shock. 2000;14:503–8.

    Article  PubMed  CAS  Google Scholar 

  50. Bulger EM, Cuschieri J, Warner K, Maier RV. Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Ann Surg. 2007;245:635–41.

    Article  PubMed  Google Scholar 

  51. Kolsen-Petersen JA, Nielsen JO, Bendtzen K, Tonnesen E. Infusion of hypertonic saline (7.5 % NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiol Scand. 2004;48:224–33.

    Article  PubMed  CAS  Google Scholar 

  52. Kolsen-Petersen JA, Nielsen JO, Tonnesen EM. Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology. 2004;100:1108–18.

    Article  PubMed  CAS  Google Scholar 

  53. Huang PP, Stucky FS, Dimick AR, Treat RC, Bessey PQ, Rue LW. Hypertonic sodium resuscitation is associated with renal failure and death. Ann Surg. 1995;221:543–54; discussion 554–7.

    Google Scholar 

  54. Suarez JI. Hypertonic saline for cerebral edema and elevated intracranial pressure. Cleve Clin J Med. 2004;71(Suppl 1):S9–13.

    Article  PubMed  Google Scholar 

  55. Wagner I, Hauer EM, Staykov D, Volbers B, Dorfler A, Schwab S, et al. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke. 2011;42:1540–5.

    Article  PubMed  Google Scholar 

  56. Hauer EM, Stark D, Staykov D, Steigleder T, Schwab S, Bardutzky J. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med. 2011;39:1766–72.

    Article  PubMed  CAS  Google Scholar 

  57. Qureshi AI, Suarez JI, Bhardwaj A, Mirski M, Schnitzer MS, Hanley DF, et al. Use of hypertonic (3 %) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med. 1998;26:440–6.

    Article  PubMed  CAS  Google Scholar 

  58. Froelich M, Ni Q, Wess C, Ougorets I, Hartl R. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37:1433–41.

    Article  PubMed  CAS  Google Scholar 

  59. Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin. 2002;20:227–39, vii.

    Google Scholar 

  60. Castilla-Guerra L, del Carmen Fernandez-Moreno M, Lopez-Chozas JM, Fernandez-Bolanos R. Electrolytes disturbances and seizures. Epilepsia. 2006;47:1990–8.

    Article  PubMed  CAS  Google Scholar 

  61. Handy JM, Soni N. Physiological effects of hyperchloraemia and acidosis. Br J Anaesth. 2008;101:141–50.

    Article  PubMed  CAS  Google Scholar 

  62. Yunos NM, Bellomo R, Story D, Kellum J. Bench-to-bedside review: chloride in critical illness. Crit Care. 2010;14:226.

    Article  PubMed  Google Scholar 

  63. McFarlane C, Lee A. A comparison of plasmalyte 148 and 0.9 % saline for intra-operative fluid replacement. Anaesthesia. 1994;49:779–81.

    Article  PubMed  CAS  Google Scholar 

  64. Reed RL 2nd, Johnston TD, Chen Y, Fischer RP. Hypertonic saline alters plasma clotting times and platelet aggregation. J Trauma. 1991;31:8–14.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Adam Schiavi for manuscript review, Claire Levine for manuscript preparation, and Patricia Lamberti for figure preparation. This work was supported by National Institutes of Health Grant NS038684 (R.C.K.).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Papangelou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papangelou, A., Toung, T.J.K., Gottschalk, A. et al. Infarct Volume After Hyperacute Infusion of Hypertonic Saline in a Rat Model of Acute Embolic Stroke. Neurocrit Care 18, 106–114 (2013). https://doi.org/10.1007/s12028-012-9768-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-012-9768-z

Keywords

Navigation